A new trading day began on Tuesday, with Applied Therapeutics Inc (NASDAQ: APLT) stock price down -2.43% from the previous day of trading, before settling in for the closing price of $0.54. APLT’s price has ranged from $0.49 to $10.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 6.97%. With a float of $92.18 million, this company’s outstanding shares have now reached $116.36 million.
In an organization with 25 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.
Applied Therapeutics Inc (APLT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 20.78%, while institutional ownership is 83.99%. The most recent insider transaction that took place on Feb 06 ’25, was worth 14,000. In this transaction an insider of this company sold 22,950 shares at a rate of $0.61, taking the stock ownership to the 404,961 shares. Before that another transaction happened on Feb 06 ’25, when Company’s Chief Medical Officer sold 86,078 for $0.61, making the entire transaction worth $52,508. This insider now owns 900,775 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.27% during the next five years compared to -8.72% drop over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Here are Applied Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.06.
Technical Analysis of Applied Therapeutics Inc (APLT)
Let’s dig in a bit further. During the last 5-days, its volume was 3.31 million. That was inferior than the volume of 4.75 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.89%. Additionally, its Average True Range was 0.08.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 0.41%, which indicates a significant decrease from 19.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.88% in the past 14 days, which was lower than the 240.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7347, while its 200-day Moving Average is $4.8177. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $0.5491. Second resistance stands at $0.5683. The third major resistance level sits at $0.5850. If the price goes on to break the first support level at $0.5132, it is likely to go to the next support level at $0.4965. Assuming the price breaks the second support level, the third support level stands at $0.4773.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
With a market capitalization of 61.67 million, the company has a total of 116,356K Shares Outstanding. Currently, annual sales are 9,990 K while annual income is -119,760 K. The company’s previous quarter sales were 120 K while its latest quarter income was -68,590 K.
